Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2000 1
2001 1
2004 1
2006 2
2008 2
2009 2
2010 2
2013 1
2014 3
2015 3
2016 7
2017 7
2018 4
2019 7
2020 9
2021 10
2022 14
2023 25
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin BH; NefIgArd Trial Investigators. Barratt J, et al. Kidney Int. 2023 Feb;103(2):391-402. doi: 10.1016/j.kint.2022.09.017. Epub 2022 Oct 19. Kidney Int. 2023. PMID: 36270561 Free article. Clinical Trial.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Liver Disease-Associated Glomerulopathies.
Kanduri SR, Peleg Y, Wadhwani S. Kanduri SR, et al. Among authors: wadhwani s. Adv Kidney Dis Health. 2024 Mar;31(2):147-156. doi: 10.1053/j.akdh.2023.11.002. Adv Kidney Dis Health. 2024. PMID: 38649219 Review.
The digital determinants of liver disease.
Wadhwani SI, Lai JC. Wadhwani SI, et al. Hepatology. 2023 Jan 1;77(1):13-14. doi: 10.1002/hep.32639. Epub 2022 Jul 4. Hepatology. 2023. PMID: 35753068 Free PMC article. No abstract available.
Geographic disparities in access to liver transplantation.
Yilma M, Dalal N, Wadhwani SI, Hirose R, Mehta N. Yilma M, et al. Among authors: wadhwani si. Liver Transpl. 2023 Sep 1;29(9):987-997. doi: 10.1097/LVT.0000000000000182. Epub 2023 May 29. Liver Transpl. 2023. PMID: 37232214 Review.
Medical Need and Transplant Accessibility-Reply.
Wadhwani SI, Lai JC, Gottlieb L. Wadhwani SI, et al. JAMA. 2022 Aug 16;328(7):679-680. doi: 10.1001/jama.2022.10412. JAMA. 2022. PMID: 35972489 No abstract available.
Pancreatic adenocarcinoma: imaging techniques for diagnosis and management.
Farrukh J, Balasubramaniam R, James A, Wadhwani SS, Albazaz R. Farrukh J, et al. Among authors: wadhwani ss. Br J Hosp Med (Lond). 2022 May 2;83(5):1-12. doi: 10.12968/hmed.2022.0065. Epub 2022 May 27. Br J Hosp Med (Lond). 2022. PMID: 35653327 Free article. Review.
Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network.
Chen DP, Helmuth ME, Smith AR, Canetta PA, Ayoub I, Mucha K, Kallash M, Kopp JB, Gbadegesin R, Gillespie BW, Greenbaum LA, Parekh RS, Hunley TE, Sperati CJ, Selewski DT, Kidd J, Chishti A, Reidy K, Mottl AK, Gipson DS, Srivastava T, Twombley KE; CureGN Consortium. Chen DP, et al. Am J Kidney Dis. 2023 Jun;81(6):695-706.e1. doi: 10.1053/j.ajkd.2022.11.012. Epub 2023 Jan 3. Am J Kidney Dis. 2023. PMID: 36608921
96 results